( en | de | ru )

 

Disambiguation of "Patel, Mahendra"

Author of the publication

copydeleteadd this publication to your clipboard
Wide-area measurement data analytics using FNET/GridEye: A review.

, , , , , , , , , and . PSCC, page 1-6. IEEE, (2016)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Mahendra Patel

Mahendra Nath

Mahendra Samarawickrama

Mahendra Doshi

Mahendra Kothari

 

Other publications of authors with the same name

Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased…, , , , , , , , , and 38 other author(s). BMJ Open, (2023)Hierarchical Frequency and Voltage Control using Prioritized Utilization of Inverter Based Resources., , , , , and . CoRR, (2021)An Integrated Frequency-Voltage Controller for Next-Generation Power Systems., , , , , , and . ISGT-Europe, page 1-6. IEEE, (2022)Adaptive and coordinated oscillation damping control using measurement-driven approach., , , , , , and . PSCC, page 1-7. IEEE, (2016)Wide-area measurement data analytics using FNET/GridEye: A review., , , , , , , , , and . PSCC, page 1-6. IEEE, (2016)Applicability of topology control algorithms (TCA) to a real-size power system., , , , , , and . Allerton, page 1349-1352. IEEE, (2013)Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE): protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk, , , , , , , , , and 16 other author(s). BMJ Open, (2021)Data-Driven Fast Frequency Control using Inverter-Based Resources., , , , , and . CoRR, (2022)Ivermectin for COVID-19 in adults in the community (PRINCIPLE): an open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes, , , , , , , , , and 15 other author(s). Journal of Infection, (2024)Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial, , , , , , , , , and 16 other author(s). Lancet, 398 (10303): 843 - 855 (2021)